×

SGEN's Adcetris Targets Lymphomas

5:34 PM ET Tue, 10 Jan 2012

Clay Siegall, Seattle Genetics president & CEO, discusses the company's cancer drug, Adcetris, and which new drugs are in the company's pipeline for 2012.